News | Wearables | May 31, 2023

Vivalink Releases 14-Day Live Stream Wearable ECG Patch for Ambulatory Cardiac Monitoring

Rechargeable multi-parameter wearable patch enables continuous and real time monitoring of remote patients 

Rechargeable multi-parameter wearable patch enables continuous and real time monitoring of remote patients

May 31, 2023 — Vivalink, a leading provider of digital healthcare solutions, is announcing the newest version of its multi-parameter wearable electrocardiogram (ECG) patch with continuous 14-day live stream capabilities. With Vivalink’s new patch, extended duration remote ECG monitoring can be performed with a single application of the patch, thereby reducing both clinician and patient burden. In addition, the real time streaming capabilities let clinicians remotely view a patient's live ECG anywhere anytime. 

Continuous or live monitoring of ECG may be indicated for post-op care after cardiac catheterization, cardiac surgery, ablation, and cryptogenic stroke. For example, a 14-day mobile cardiac telemetry session can be performed with a single application of the patch. And at any given time, a cardiologist can view the patient’s ECG live as though the patient is in the clinic, to adjudicate events such as arrhythmias and to confirm the patient’s current status. 

“Advancements in digital healthcare technologies are enabling a new class of applications such as acute patient monitoring and virtual hospitals,” said Jiang Li, CEO of Vivalink. “The new 14-day ECG patch is just another example of Vivalink’s innovation in the world of digital healthcare solutions.” 

In addition to parameters such as HRV, respiratory rate, and skin temperature, other features of the 14-day ECG patch include:  

  • Step Count - ability to measure the number of steps taken 
  • Activity Level - ability to measure the intensity of movement 
  • Posture Detection - ability to detect position  
  • 14-Day Adhesive - water resistant, continuous wear 

 

Together with Vivalink’s other medical wearable sensors, the monitoring of human vitals (e.g. ECG, heart rate, respiratory rate, temperature, Sp02, blood pressure) can be performed remotely, continuously, and in real time. 

For more information, visit www.vivalink.com.  

 

Related Wearable ECG Monitoring Content: 

How Advances in Wearable Cardiac Monitors Improve the Patient and Clinician Experience 

Longer Continuous Ambulatory Cardiac Monitoring Enables More Comprehensive Evaluation of Atrial Fibrillation 

Cardea Solo Wearable ECG Collects High-altitude Cardiac Data on Denali Expedition 

Cardiac Insight Partners With VivoSense for Cardiovascular Research 

Wearable Cardiac Monitors Are Effective for Tracking Atrial Fibrillation Following Ablation 

As Interpretation Criteria Evolve, False Positive Athlete ECG Screening Rates Can Decrease 


Related Content

Feature | ECG | Samir Awasthi, MD, PhD

For decades, medicine has treated the electrocardiogram as a familiar, inexpensive and indispensable test, but also as ...

Home June 16, 2026
Home
News | ECG

June 2, 2026 —HeartSciences Inc. has announced the commercial release of MyoVista Insights version 1.3, a major platform ...

Home June 05, 2026
Home
News | ECG

June 2, 2026 — AccurKardia, Inc. has been granted US Patent No. 12,620,488 for the company's proprietary machine ...

Home June 02, 2026
Home
News | ECG

May 7, 2026 — AccurKardia, a provider of ECG-based diagnostics technology, recently announced that AK+ Guard has been ...

Home May 08, 2026
Home
News | ECG

April 15, 2026 – AliveCor has received CE Mark (Conformité Européenne) for the Kardia 12L electrocardiogram (ECG) System ...

Home April 15, 2026
Home
News | ECG

March 4, 2026 — HeartBeam, Inc. has announced a commercial partnership with ClearCardio. In addition to serving as ...

Home March 06, 2026
Home
News | ECG

March 3, 2026 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for treating cardiovascular and ...

Home March 04, 2026
Home
News | ECG

Feb. 10, 2026 – AccurKardia, a provider of ECG-based diagnostics technology, recently announced results from a new study ...

Home February 24, 2026
Home
News | ECG

Feb. 18, 2026 — Researchers at the Mount Sinai Kravis Children’s Heart Center led a multicenter effort to develop and ...

Home February 20, 2026
Home
News | ECG

Dec. 10, 2025 — The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to HeartBeam, Inc. for its 12 ...

Home February 16, 2026
Home
Subscribe Now